Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection

Therapeutic Drug Monitoring

Volumn 33, Issue 2, 2011, Pages 209-213

  Juenke, Joetta M ^a   Brown, Paul I ^a   Johnson Davis, Kamisha L ^a,b   McMillin, Gwendolyn A ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

anticonvulsants by UPLC MS MS; gabapentin; levetiracetam; therapeutic drug monitoring

Indexed keywords

2 NAPHTHOIC ACID DERIVATIVE; 3 AMINO 2 NAPHTHOIC ACID; ACETONITRILE; ETIRACETAM; FORMIC ACID; GABAPENTIN; METHANOL; UNCLASSIFIED DRUG; WATER;

ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PRESSURE LIQUID CHROMATOGRAPHY;

AMINES; ANTICONVULSANTS; CHROMATOGRAPHY, LIQUID; CYCLOHEXANECARBOXYLIC ACIDS; DRUG MONITORING; GAMMA-AMINOBUTYRIC ACID; HUMANS; PIRACETAM; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 79953186567     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31820b1fce     Document Type: Article

References (39)

1. To TP, Lim TC, Hill ST, et al. Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord. 2002;40:282-285. (Pubitemid 34628097)
2. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systemic review of controlled and uncontrolled literature. Clin J Pain. 2001;17:284-295. (Pubitemid 33152000)
3. Putzke JD, Richards JS, Kezar L, et al. Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin J Pain. 2002;18: 116-121. (Pubitemid 34205402)
4. Berigan TR. Gabapentin and PTSD. J Clin Psychiatry. 2002;63:744.
5. Chen B, Stitik TP, Foye PM, et al. Central post-stroke pain syndrome: yet another use for gabapentin? Am J Phys Med Rehabil. 2002;81:718-720. (Pubitemid 34982988)
6. Gilron I. Is gabapentin a "broad spectrum" analgesic? Anesthesiology. 2002;97:537-539.
7. Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57:451-462. (Pubitemid 34477042)
8. Bozikas V, Petrikis P, Gamvrula K, et al. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26: 197-199. (Pubitemid 34045168)
9. Schoonman GG, Wiendels NJ, Ferrari MD. Gabapentin in migraine prophylaxis: is it effective and well tolerated? Headache. 2002;42:235.
10. Jeffery SM, Pepe JJ, Popvich LM, et al. Gabapentin for hot flashes in prostate cancer. Ann Pharmacother. 2002;36:433-436. (Pubitemid 34205316)
11. Chandler A, Williams JE. Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital. J Pain Symptom Manage. 2000; 20:82-86.
12. Dirks J, Fredensborg BB, Christensen D, et al. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97: 560-564. (Pubitemid 34977313)
13. Physician's Desk Reference. 56th ed. Montvale, NJ: Medical Economics Company 2002.
14. Gidal BE, Radulovic LL, Kruger S, et al. Inter- and Intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res. 2000;40:123-127. (Pubitemid 30339403)
15. Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiseizure drugs? Epilepsia. 2001;42(Suppl 4):S13-S18.
16. Radke R. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42(Suppl 4):S24-S27.
17. Leppik IE. The place of levetiracetam in the treatment of epilepsy. Epilepsia. 2001;42(Suppl 4):S44-S45.
18. Ben-Menachem E, Edrich P, Van Vleymen B, et al. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res. 2003; 53:57-64. (Pubitemid 36170171)
19. Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug monitoring of the newer antiseizure drugs. Ther Drug Monit. 2003;25:347-363. (Pubitemid 36638181)
20. Lamberty Y, Gower AJ, Klitgaard H. The new antiseizure drug levetiracetam normalizes chlordiazepoxide withdrawal-induced anxiety in mice. Eur J Pharmacol. 2002;439:101-106. (Pubitemid 34286612)
21. Frucht SJ, Louis ED, Chuang C, et al. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology. 2001;57:1112-1114. (Pubitemid 32880216)
22. Krauss GL, Bergin A, Kramer RE, et al. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology. 2001;56: 411-412. (Pubitemid 32144160)
23. Barrueto f, Williams K, Howland MA, et al. A case of levetiracetam poisoning with clinical and toxicokinetic data. J Toxicol Clin Toxicol. 2002;40:881-884. (Pubitemid 36076741)
24. Alsaadi TM, Thieman C. Levetiracetam monotherapy for newly diagnosed epilepsy patients. Seizure. 2003;12:154-156. (Pubitemid 36452286)
25. FarooqMIJ, Bhatt A,Majid A, et al. Levetiracetam for managing neurological and psychiatric disorders. Am J Health Syst Pharm. 2009;66:541-561.
26. ARKTM Levetiracetam Assay. Ark Diagnostics, Inc. Available at: http:// www.ark-tdm.com/Dashboard/DB-levetiracetam.html. Accessed August 30, 2010.
27. Lensmeyer GL, Kempf T, Gidal BE, et al. Optimized method for determination of gabapentin in serum by high performance liquid chromatography. Ther Drug Monit. 1995;17:251-258.
28. Ifa DR, Falci M, Moraes ME, et al. Gabapentin quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivence study. J Mass Spectrom. 2001;36:188-194. (Pubitemid 32186236)
29. Juenke JM, Brown PI, McMillin GA, et al. Procedure for the monitoring of gabapentin with 2,4,6-trinitrobenzene sulfonic acid derivatization followed by HPLC with ultraviolet detection. Clin Chem. 2003;49:1198-1201. (Pubitemid 36751114)
30. Juenke JM, Brown PI, Urry FM, et al. A procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV. J Anal Toxicol. 2006;30:27-30. (Pubitemid 44270339)
31. Blonk MI, van der Nagel BC, Smit LS, et al. Quantification of levetiracetam in plasma of neonates by ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:675-681.
32. Oertel R, Arenz N, Pietsch J, et al. Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. J Sep Sci. 2009;32: 238-243.
33. Kushnir MM, Crossett J, Brown PI, et al. Anaylsis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography-mass spectrometry for therapeutic drug monitoring. J Anal Toxicol. 1999;23:1-6. (Pubitemid 29327445)
34. Wolf CE, Saady JJ, Pokis A. Determination of gabapentin in serum using solid-phase extraction and gas-liquid chromatography. J Anal Toxicol. 1996;20:498-501. (Pubitemid 26327473)
35. Greiner-Sosanko E, Giannoutsos S, Lower DR, et al. Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphurus detector for levetiracetam. J Chomatogr Sci. 2007; 45:616-622. (Pubitemid 350005265)
36. Al-Zehouri J, al-Madi S, Belal F. Determination of the antiepileptics vigabatrin and gabapentin in dosage forms and biological fluids using Hantzsch reaction. Arzneimittelforschung. 2001;51:97-103. (Pubitemid 32176241)
37. Hassan EM, Belal F, Al-Deeb OA, et al, Spectrofluorimetric determination of vigabatrin and gabapentin in dosage forms and spiked plasma samples through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole. J AOAC Int. 2001;84:1017-1024. (Pubitemid 33610531)
38. Belal F, Abdine H, Al-Majed A, et al. Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine. J Pharm Biomed Anal. 2002;27:253-260. (Pubitemid 33001403)
39. Garcia LL, Shihabi ZK, Oles K. Determination of gabapentin in serum by capillary electrophoresis. J Chromatogr B Biomed Appl. 1995;669:157-162.